GlaxoSmithKline (GSK) has signed its first agreement with the 探花直播 to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Cambridge researchers have discovered that measuring activity in a region of the brain could help to identify people at risk of developing obsessive compulsive disorder (OCD).